Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification
about
Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification
description
clinical trial
@en
klinisch onderzoek
@nl
name
Carvedilol for the Prevention ...... for Early Risk Stratification
@en
Carvedilol for the Prevention ...... for Early Risk Stratification
@nl
type
label
Carvedilol for the Prevention ...... for Early Risk Stratification
@en
Carvedilol for the Prevention ...... for Early Risk Stratification
@nl
prefLabel
Carvedilol for the Prevention ...... for Early Risk Stratification
@en
Carvedilol for the Prevention ...... for Early Risk Stratification
@nl
P1476
Carvedilol for the Prevention ...... for Early Risk Stratification
@en
P3098
NCT02177175
P4844
P580
2014-06-01T00:00:00Z
P582
2020-06-01T00:00:00Z